Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient

Alessandro Broccoli, Cinzia Pellegrini, Monica Celli, Lisa Argnani, Claudio Agostinelli, Stefano Pileri, Pier Luigi Zinzani

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
JournalClinical Lymphoma, Myeloma and Leukemia
Volume14
Issue number4
DOIs
Publication statusPublished - 2014

Keywords

  • Angioimmunoblastic T-cell lymphoma
  • Complete response
  • Lenalidomide
  • Splenomegaly
  • Vascular-endothelial growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology
  • Medicine(all)

Cite this

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient. / Broccoli, Alessandro; Pellegrini, Cinzia; Celli, Monica; Argnani, Lisa; Agostinelli, Claudio; Pileri, Stefano; Zinzani, Pier Luigi.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 14, No. 4, 2014.

Research output: Contribution to journalArticle

Broccoli, Alessandro ; Pellegrini, Cinzia ; Celli, Monica ; Argnani, Lisa ; Agostinelli, Claudio ; Pileri, Stefano ; Zinzani, Pier Luigi. / Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient. In: Clinical Lymphoma, Myeloma and Leukemia. 2014 ; Vol. 14, No. 4.
@article{c7f3853e0b70430791ba3033465b830c,
title = "Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient",
keywords = "Angioimmunoblastic T-cell lymphoma, Complete response, Lenalidomide, Splenomegaly, Vascular-endothelial growth factor",
author = "Alessandro Broccoli and Cinzia Pellegrini and Monica Celli and Lisa Argnani and Claudio Agostinelli and Stefano Pileri and Zinzani, {Pier Luigi}",
year = "2014",
doi = "10.1016/j.clml.2014.01.011",
language = "English",
volume = "14",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2669",
publisher = "Cancer Media Group",
number = "4",

}

TY - JOUR

T1 - Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient

AU - Broccoli, Alessandro

AU - Pellegrini, Cinzia

AU - Celli, Monica

AU - Argnani, Lisa

AU - Agostinelli, Claudio

AU - Pileri, Stefano

AU - Zinzani, Pier Luigi

PY - 2014

Y1 - 2014

KW - Angioimmunoblastic T-cell lymphoma

KW - Complete response

KW - Lenalidomide

KW - Splenomegaly

KW - Vascular-endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84904556753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904556753&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2014.01.011

DO - 10.1016/j.clml.2014.01.011

M3 - Article

C2 - 24629851

AN - SCOPUS:84904556753

VL - 14

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2669

IS - 4

ER -